Antibodies News and Research

RSS

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Elan and Wyeth receive patents for Alzheimer's disease treatments

Elan Corporation and Wyeth Pharmaceuticals have announced that the United States Patent and Trademark Office recently issued Neuralab Limited, a subsidiary of Elan, seven patents for the companies’ joint research on immunotherapeutic approaches to the prevention and treatment of Alzheimer’s disease.

23 Sep 2004

New gene therapy technique may help treat Alzheimer's disease

Investigators at Rush University Medical Center have successfully initiated a new technique that uses gene therapy to deliver nerve growth factor into regions of the brain where neurons are degenerating, in order to prevent cell death and reverse cell atrophy, two hallmarks of Alzheimer's disease.

21 Sep 2004

Stress response proteins offer a promising target for a novel drug guidance system

Their study, published in the September issue of the journal Cancer Cell, demonstrates how researchers can find protein tags that are unique to cancer cells and then tweak a drug delivery system to zero in on those tags and destroy the cells.

21 Sep 2004

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

The Chairman of the U.S. Senate Special Committee on Aging is encouraging those on Medicare who have cancer and other serious diseases to consider signing up for a new demonstration prescription drug assistance program.

18 Sep 2004

Neck surgeons brush up on West Nile virus

Neck Surgery Foundation Annual Meeting & OTO EXPO, being held September 19-22, 2004, at the Jacob K. Javits Convention Center, New York City, NY.

17 Sep 2004

The same gene functions in vision and immune system, research shows

Scientists have learned that a family of genes long known to be integral to the immune system also plays a role in vision, perhaps preventing certain blinding diseases.

16 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

Immunoglobulins might be promising treatment for Alzheimer's disease

Intravenous immunoglobulin might offer a promising treatment for Alzheimer's disease, suggests preliminary research in the Journal of Neurology Neurosurgery and Psychiatry.

15 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Long-term outcomes for liver transplantation due to hepatitis C

A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases.

8 Sep 2004

MorphoSys obtains license on human cell line technology for use in its antibody research

MorphoSys has announced today a non-exclusive license agreement with Dutch biotechnology company Crucell and DSM Biologics.

8 Sep 2004

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

Stopping bacteria from talking to each other could help prevent serious infections

Stopping bacteria from talking to each other could help prevent serious infections say scientists from Aberdeen, in new research presented Monday at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

7 Sep 2004

Hair growing stem cells may one day provide treatments for human hair conditions

Researchers at the Howard Hughes Medical Institute at The Rockefeller University have isolated stem cells from the skin of a mouse, and showed, for the first time, that an individual stem cell can renew itself in the laboratory and then be used in grafts to produce skin, hair and oil glands.

5 Sep 2004

Major trends in AIDS research that the different research teams throughout the world are pursuing

The science will be presented during the conference which is taking place in Lausanne until September 1, 2004. The advances in fundamental research, notably through a better understanding of the complex processes of immune defence, HIV and the functioning of vaccines, promote the genesis and development of new vaccine candidates.

30 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Researchers find how cancers, particularly lymphomas, develop and might be prevented

Researchers at Children's Hospital Boston have begun unraveling the mystery of how B lymphocytes - key infection-fighting cells in the body - are able to create many different kinds of specialized antibodies through selective gene mutations, while being protected from random mutations that could give rise to cancers.

23 Aug 2004

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Two upcoming studies by scientists at the National Cancer Institute (NCI), provide further evidence that exposure to simian virus 40 (SV40) is not associated with cancer in humans.

23 Aug 2004

Surprise finding could lead to hepatitis C vaccine

New research from the University of New South Wales shows some people may repeatedly be able to clear hepatitis C virus from their bodies, without any biological traces of the potentially serious infection.

23 Aug 2004

Antibodies News and Research

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Elan and Wyeth receive patents for Alzheimer's disease treatments

New gene therapy technique may help treat Alzheimer's disease

Stress response proteins offer a promising target for a novel drug guidance system

So far only 4,000 of 50,000 slots have been filled in new demonstration prescription drug assistance program

Neck surgeons brush up on West Nile virus

The same gene functions in vision and immune system, research shows

Cancer drug effective at treating lupus

Immunoglobulins might be promising treatment for Alzheimer's disease

Researchers uncover how HIV causes abnormalities in antibody-producing cells

Long-term outcomes for liver transplantation due to hepatitis C

MorphoSys obtains license on human cell line technology for use in its antibody research

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Stopping bacteria from talking to each other could help prevent serious infections

Hair growing stem cells may one day provide treatments for human hair conditions

Major trends in AIDS research that the different research teams throughout the world are pursuing

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Researchers find how cancers, particularly lymphomas, develop and might be prevented

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Surprise finding could lead to hepatitis C vaccine

Immunology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News